Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.6M Buy
382,934
+30,862
+9% +$1.1M ﹤0.01% 1980
2026
Q1
$10.6M Buy
352,072
+67,902
+24% +$2.15M ﹤0.01% 2072
2025
Q4
$8.3M Buy
284,170
+65,067
+30% +$1.72M ﹤0.01% 2223
2025
Q3
$5.72M Buy
219,103
+65,780
+43% +$1.63M ﹤0.01% 2378
2025
Q2
$3.45M Buy
153,323
+7,731
+5% +$159K ﹤0.01% 2491
2025
Q1
$3.04M Buy
145,592
+6,297
+5% +$132K ﹤0.01% 2475
2024
Q4
$2.96M Buy
139,295
+8,250
+6% +$181K ﹤0.01% 2550
2024
Q3
$3.04M Buy
131,045
+14,920
+13% +$351K ﹤0.01% 2584
2024
Q2
$2.58M Buy
116,125
+24,270
+26% +$518K ﹤0.01% 2613
2024
Q1
$2.02M Buy
91,855
+21,525
+31% +$438K ﹤0.01% 2590
2023
Q4
$1.31M Buy
70,330
+16,890
+32% +$307K ﹤0.01% 2751
2023
Q3
$1M Buy
53,440
+24,855
+87% +$464K ﹤0.01% 2797
2023
Q2
$521K Buy
28,585
+15,615
+120% +$271K ﹤0.01% 3037
2023
Q1
$213K Buy
+12,970
New +$222K ﹤0.01% 3142

Other funds holding IX

Charles Schwab's IX Position: Q2 2026 in Review

Charles Schwab increased its ORIX (IX) stake by 8.8% in Q2 2026, buying an estimated $1.1M and bringing the position to 382,934 shares worth $14.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1980.

Charles Schwab first reported a position in IX in Q1 2023 and has held it in 14 quarters since. 320 funds tracked by Wall St. Rank hold IX as of Q2 2026.

  • Charles Schwab held 382,934 shares of ORIX worth $14.6M as of Q2 2026.
  • Charles Schwab bought 30,862 ORIX shares in Q2 2026, an estimated $1.1M.
  • ORIX made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #1980 holding.
  • Charles Schwab first reported a position in ORIX in Q1 2023 and has held it in 14 quarters since.
  • 320 funds tracked by Wall St. Rank held ORIX as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.